• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons

tetano

Editor, Senior Moderator
Cell Rep Med


. 2020 Nov 10;1(9):100146.
doi: 10.1016/j.xcrm.2020.100146. eCollection 2020 Dec 22.
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons


Nils Rother[SUP] 1 [/SUP], Cansu Yanginlar[SUP] 1 [/SUP], Rik G H Lindeboom[SUP] 2 [/SUP], Siroon Bekkering[SUP] 3 [/SUP], Mandy M T van Leent[SUP] 4 5 [/SUP], Baranca Buijsers[SUP] 1 [/SUP], Inge Jonkman[SUP] 1 [/SUP], Mark de Graaf[SUP] 1 [/SUP], Marijke Baltissen[SUP] 2 [/SUP], Lieke A Lamers[SUP] 2 [/SUP], Niels P Riksen[SUP] 3 [/SUP], Zahi A Fayad[SUP] 4 [/SUP], Willem J M Mulder[SUP] 4 6 7 [/SUP], Luuk B Hilbrands[SUP] 1 [/SUP], Leo A B Joosten[SUP] 3 [/SUP], Mihai G Netea[SUP] 3 8 [/SUP], Michiel Vermeulen[SUP] 2 [/SUP], Johan van der Vlag[SUP] 1 [/SUP], Rapha?l Duivenvoorden[SUP] 1 4 [/SUP]



Affiliations
Free PMC article

Abstract

Hydroxychloroquine is being investigated for a potential prophylactic effect in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but its mechanism of action is poorly understood. Circulating leukocytes from the blood of coronavirus disease 2019 (COVID-19) patients show increased responses to Toll-like receptor ligands, suggestive of trained immunity. By analyzing interferon responses of peripheral blood mononuclear cells from healthy donors conditioned with heat-killed Candida, trained innate immunity can be modeled in vitro. In this model, hydroxychloroquine inhibits the responsiveness of these innate immune cells to virus-like stimuli and interferons. This is associated with a suppression of histone 3 lysine 27 acetylation and histone 3 lysine 4 trimethylation of inflammation-related genes, changes in the cellular lipidome, and decreased expression of interferon-stimulated genes. Our findings indicate that hydroxychloroquine inhibits trained immunity in vitro, which may not be beneficial for the antiviral innate immune response to SARS-CoV-2 infection in patients.

Keywords: COVID-19; SARS-CoV-2; chloroquine; hydroxychloroquine; innate immune memory; interferon; lipidome; monocytes; trained immunity.
 
Back
Top Bottom